Trial intelligence / Profile preview

Dexmedetomidine and hemodynamic changes in cholecystectomy

IRCT20210508051221N1Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine in cholecystitis, sponsored by Arak University of Medical Sciences. Started Jun 2021; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

cholecystitis

Beyond the preview

Go deeper on IRCT20210508051221N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210508051221N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call